The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Daunorubicin

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Daunorubicin.
Olatoyosi Odenike
Connection Strength
0.045
Daunorubicin
  1. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial. Nat Med. 2020 12; 26(12):1852-1858.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.